HIV heart risk targeted: new drug trial aims to quiet arterial inflammation
Disease control
Recruiting now
This study tests whether bempedoic acid, a cholesterol-lowering drug, can reduce artery inflammation and improve heart health in people with HIV. About 121 adults aged 40 and older with well-controlled HIV and at least one heart disease risk factor will receive either the drug or…
Phase: PHASE2 • Sponsor: Priscilla Hsue, MD • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC